• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾脏类器官作为肾脏病学中一种有前景的工具。

Kidney organoids as a promising tool in nephrology.

作者信息

Wu Mengyuan, Hu Tingting, Zhu Ping, Nasser Moussa Ide, Shen Jie, Sun Fang, He Qingnan, Zhao Mingyi

机构信息

Department of Pediatrics, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, PR China.

XiangYa School of Medicine, Central South University, Changsha, Hunan 410013, PR China.

出版信息

Genes Dis. 2021 Jan 30;9(3):585-597. doi: 10.1016/j.gendis.2021.01.003. eCollection 2022 May.

DOI:10.1016/j.gendis.2021.01.003
PMID:35782972
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9243316/
Abstract

Kidney disease has become a global public health problem affecting over 750 million people worldwide and imposing a heavy economic burden on patients. The complex architecture of the human kidney makes it very difficult to study the pathophysiology of renal diseases and to develop effective therapeutic options for patients. Even though cell lines and animal models have enriched our understanding, they fail to recapitulate key aspects of human kidney development and renal disease at cellular and functional levels. Organoids can be derived from either pluripotent stem cells or adult stem cells by strictly regulating key signalling pathways. Today, these self-differentiated organoids represent a promising technology to further understand the human kidney, one of the most complex organs, in an unprecedented way. The newly established protocols improved by organ-on-chip and coculture with immune cells will push kidney organoids towards the next generation. Herein, we focus on recent achievements in the application of kidney organoids in disease modelling, nephrotoxic testing, precision medicine, biobanking, and regenerative therapy, followed by discussions of novel strategies to improve their utility for biomedical research. The applications we discuss may help to provide new ideas in clinical fields.

摘要

肾脏疾病已成为一个全球性的公共卫生问题,影响着全球超过7.5亿人,并给患者带来沉重的经济负担。人类肾脏的复杂结构使得研究肾脏疾病的病理生理学以及为患者开发有效的治疗方案变得非常困难。尽管细胞系和动物模型丰富了我们的认识,但它们无法在细胞和功能水平上重现人类肾脏发育和肾脏疾病的关键方面。通过严格调控关键信号通路,类器官可以从多能干细胞或成体干细胞中获得。如今,这些自我分化的类器官代表了一种有前途的技术,以前所未有的方式进一步了解人类最复杂的器官之一——肾脏。通过芯片器官和与免疫细胞共培养改进的新建立方案将推动肾脏类器官迈向新一代。在此,我们重点关注肾脏类器官在疾病建模、肾毒性测试、精准医学、生物样本库和再生治疗中的应用的最新成果,随后讨论提高其在生物医学研究中效用的新策略。我们讨论的这些应用可能有助于在临床领域提供新的思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fe1/9243316/51f92a30ffca/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fe1/9243316/521e6660d925/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fe1/9243316/e2c758f4ceba/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fe1/9243316/571cbcd8ef06/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fe1/9243316/51f92a30ffca/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fe1/9243316/521e6660d925/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fe1/9243316/e2c758f4ceba/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fe1/9243316/571cbcd8ef06/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fe1/9243316/51f92a30ffca/gr4.jpg

相似文献

1
Kidney organoids as a promising tool in nephrology.肾脏类器官作为肾脏病学中一种有前景的工具。
Genes Dis. 2021 Jan 30;9(3):585-597. doi: 10.1016/j.gendis.2021.01.003. eCollection 2022 May.
2
Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases.类器官作为改善肾脏疾病再生医学和癌症个体化治疗的新模式。
Cell Death Dis. 2019 Feb 27;10(3):201. doi: 10.1038/s41419-019-1453-0.
3
Kidney Disease Modeling with Organoids and Organs-on-Chips.类器官和器官芯片在肾脏病模型中的应用。
Annu Rev Biomed Eng. 2024 Jul;26(1):383-414. doi: 10.1146/annurev-bioeng-072623-044010. Epub 2024 Jun 20.
4
Stem cell-derived kidney cells and organoids: Recent breakthroughs and emerging applications.干细胞衍生的肾脏细胞和类器官:最新突破和新兴应用。
Biotechnol Adv. 2017 Mar-Apr;35(2):150-167. doi: 10.1016/j.biotechadv.2016.12.001. Epub 2016 Dec 23.
5
[Kidney organoids].[肾脏类器官]
Med Sci (Paris). 2019 May;35(5):470-477. doi: 10.1051/medsci/2019090. Epub 2019 May 22.
6
The Utility of Human Kidney Organoids in Modeling Kidney Disease.人类肾类器官在肾脏疾病建模中的应用。
Semin Nephrol. 2020 Mar;40(2):188-198. doi: 10.1016/j.semnephrol.2020.01.009.
7
Next-Generation Liver Medicine Using Organoid Models.利用类器官模型的新一代肝脏医学
Front Cell Dev Biol. 2019 Dec 20;7:345. doi: 10.3389/fcell.2019.00345. eCollection 2019.
8
Applications of kidney organoids derived from human pluripotent stem cells.源自人类多能干细胞的肾类器官的应用。
Korean J Intern Med. 2018 Jul;33(4):649-659. doi: 10.3904/kjim.2018.198. Epub 2018 Jun 28.
9
Intestinal organoids: A new paradigm for engineering intestinal epithelium in vitro.肠类器官:体外工程化肠上皮的新范例。
Biomaterials. 2019 Feb;194:195-214. doi: 10.1016/j.biomaterials.2018.12.006. Epub 2018 Dec 10.
10
Liver Organoids: Formation Strategies and Biomedical Applications.肝类器官:形成策略与生物医学应用
Tissue Eng Regen Med. 2021 Aug;18(4):573-585. doi: 10.1007/s13770-021-00357-w. Epub 2021 Jun 16.

引用本文的文献

1
Kidney Fibrosis In Vitro and In Vivo Models: Path Toward Physiologically Relevant Humanized Models.肾纤维化的体外和体内模型:迈向生理相关人源化模型的路径。
Adv Healthc Mater. 2025 Apr;14(9):e2403230. doi: 10.1002/adhm.202403230. Epub 2025 Feb 5.
2
Generation and maintenance of kidney and kidney cancer organoids from patient-derived material for drug development and precision oncology.利用患者来源的材料生成和维持用于药物开发和精准肿瘤学的肾脏及肾癌类器官。
Mol Ther Methods Clin Dev. 2024 Nov 5;32(4):101368. doi: 10.1016/j.omtm.2024.101368. eCollection 2024 Dec 12.
3
The Road to Precision Medicine for Acute Kidney Injury.

本文引用的文献

1
Induced pluripotent stem cells provide mega insights into kidney disease.诱导多能干细胞为肾脏疾病提供了深刻的见解。
Kidney Int. 2020 Jul;98(1):54-57. doi: 10.1016/j.kint.2020.04.033.
2
Cellular and Extracellular Components in Tumor Microenvironment and Their Application in Early Diagnosis of Cancers.肿瘤微环境中的细胞和细胞外成分及其在癌症早期诊断中的应用。
Anal Cell Pathol (Amst). 2020 Jan 8;2020:6283796. doi: 10.1155/2020/6283796. eCollection 2020.
3
Blockade of SARS-CoV-2 infection by recombinant soluble ACE2.重组可溶性血管紧张素转换酶2对严重急性呼吸综合征冠状病毒2感染的阻断作用
急性肾损伤的精准医疗之路
Crit Care Med. 2024 Jul 1;52(7):1127-1137. doi: 10.1097/CCM.0000000000006328. Epub 2024 Jun 13.
4
Bibliometric and visualized analysis of hydrogels in organoids research.类器官研究中水凝胶的文献计量学与可视化分析
Regen Ther. 2024 Feb 23;25:395-404. doi: 10.1016/j.reth.2024.02.004. eCollection 2024 Mar.
5
Human induced pluripotent stem cell-derived planar neural organoids assembled on synthetic hydrogels.在合成水凝胶上组装的人诱导多能干细胞来源的平面神经类器官。
J Tissue Eng. 2024 Feb 14;15:20417314241230633. doi: 10.1177/20417314241230633. eCollection 2024 Jan-Dec.
6
Advancing drug discovery for glomerulopathies using stem-cell-derived kidney models.利用干细胞衍生的肾脏模型推进肾小球疾病的药物发现。
Trends Pharmacol Sci. 2023 Apr;44(4):204-207. doi: 10.1016/j.tips.2022.12.001. Epub 2022 Dec 22.
Kidney Int. 2020 Jun;97(6):1091-1093. doi: 10.1016/j.kint.2020.04.009. Epub 2020 Apr 14.
4
Black Phosphorus Quantum Dots Cause Nephrotoxicity in Organoids, Mice, and Human Cells.黑磷量子点在类器官、小鼠和人类细胞中引发肾毒性。
Small. 2020 Jun;16(22):e2001371. doi: 10.1002/smll.202001371. Epub 2020 Apr 27.
5
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2.使用临床级别的可溶性人血管紧张素转化酶 2 抑制工程化人类组织中的 SARS-CoV-2 感染。
Cell. 2020 May 14;181(4):905-913.e7. doi: 10.1016/j.cell.2020.04.004. Epub 2020 Apr 24.
6
SARS-CoV-2 infection of kidney organoids prevented with soluble human ACE2.可溶性人血管紧张素转换酶2可预防严重急性呼吸综合征冠状病毒2对肾类器官的感染。
Nat Rev Nephrol. 2020 Jun;16(6):316. doi: 10.1038/s41581-020-0291-8.
7
An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity.用于儿童肾癌的类器官生物库,可捕获疾病和组织异质性。
Nat Commun. 2020 Mar 11;11(1):1310. doi: 10.1038/s41467-020-15155-6.
8
Evaluation of cisplatin-induced injury in human kidney organoids.评估顺铂诱导的人肾类器官损伤。
Am J Physiol Renal Physiol. 2020 Apr 1;318(4):F971-F978. doi: 10.1152/ajprenal.00597.2019. Epub 2020 Mar 9.
9
Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target.血管紧张素转换酶2(ACE2)作为严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的受体:分子机制与潜在治疗靶点
Intensive Care Med. 2020 Apr;46(4):586-590. doi: 10.1007/s00134-020-05985-9. Epub 2020 Mar 3.
10
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.2019 年新型冠状病毒刺突蛋白在预融合构象的冷冻电镜结构
Science. 2020 Mar 13;367(6483):1260-1263. doi: 10.1126/science.abb2507. Epub 2020 Feb 19.